Cargando…
Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment
Liver disease is an important cause of mortality in type 2 diabetes mellitus (T2DM). It is estimated that diabetes is the most common cause of liver disease in the United States. Virtually, entire spectrum of liver disease is seen in T2DM including abnormal liver enzymes, nonalcoholic fatty liver di...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367241/ https://www.ncbi.nlm.nih.gov/pubmed/28459036 http://dx.doi.org/10.4103/ijem.IJEM_512_16 |